APA (7th ed.) Citation

I, K., MU, K., S, I., MU, G., I, A., L, F., . . . D, C. (2024). Thapsigargin and its prodrug derivatives: Exploring novel approaches for targeted cancer therapy through calcium signaling disruption. Medical oncology (Northwood, London, England), 42(1), 7. https://doi.org/10.1007/s12032-024-02541-z

Chicago Style (17th ed.) Citation

I, Khurram, et al. "Thapsigargin and Its Prodrug Derivatives: Exploring Novel Approaches for Targeted Cancer Therapy Through Calcium Signaling Disruption." Medical Oncology (Northwood, London, England) 42, no. 1 (2024): 7. https://doi.org/10.1007/s12032-024-02541-z.

MLA (9th ed.) Citation

I, Khurram, et al. "Thapsigargin and Its Prodrug Derivatives: Exploring Novel Approaches for Targeted Cancer Therapy Through Calcium Signaling Disruption." Medical Oncology (Northwood, London, England), vol. 42, no. 1, 2024, p. 7, https://doi.org/10.1007/s12032-024-02541-z.